NASDAQ •
Healthcare •
Diagnostics & Research •
Quote as of 05/15/2026
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization3,093.56 mln
Float79.35 mln
Earnings Date08/11/2026
EPS
1.08
Stretched
P / E
35.63
Overvalued
Piotroski F-Score
7
/ 9
Strong
Beneish M-Score
-2.6
Likely reliable
1-Year Forecast
47.40
Attractive
Relative Strength
93
/ 100
Top performer
Business Description
Veracyte is a medical testing company based in South San Francisco, California, that helps doctors detect and diagnose several types of cancer, including thyroid, prostate, bladder, breast, and lung cancer. The company develops genomic tests that analyze biological samples to give physicians clearer information when making treatment decisions. Founded in 2006, Veracyte sells its products and services to customers in the United States and around the world.
